NCT02996487View on ClinicalTrials.gov

Screening to Prophylax Against Clostridium Difficile Infection -

PHASE4CompletedINTERVENTIONAL
Enrollment

1,294

Participants

Timeline

Start Date

December 19, 2016

Primary Completion Date

June 28, 2023

Study Completion Date

June 28, 2023

Conditions
Clostridium Difficile Infection
Interventions
DRUG

Vancomycin

OTHER

Placebo

Trial Locations (3)

48073

William Beaumont Hospital, Royal Oak

48085

William Beaumont Hospital, Troy

48124

William Beaumont Hospital, Dearborn

All Listed Sponsors
lead

William Beaumont Hospitals

OTHER

NCT02996487 - Screening to Prophylax Against Clostridium Difficile Infection - | Biotech Hunter | Biotech Hunter